![]() |
|
|
TJ Lee, S Sarwinski, T Ishine, CC Lai and FY Chen
Department of Pharmacology, Southern Illinois University School of Medicine, Springfield, USA.
The possibility that L-citrulline is able to reverse inhibition of neurogenic vasodilation in isolated porcine cerebral arteries produced by nitric oxide synthase (NOS) inhibitors and Gln was examined by using in vitro tissue bath techniques. The results indicated that transmural nerve stimulation elicited a frequency-dependent and tetrodotoxin- sensitive vasodilation in isolated ring segments of arteries with or without endothelial cells. The dilation was abolished by L-N-omega- nitro-L-Arg and L-N-omega-L-Arg methyl ester and was completely reversed by L-citrulline, but not by D-citrulline. In parallel studies, the transmural nerve stimulation-induced relaxation was blocked in part by Gln. The blockade was completely reversed by L-citrulline and L-Arg, but not by their D-enantiomers. The time courses of relaxation after L- citrulline reversal of inhibition of vasodilation produced by Gln and NOS inhibitors were identical to that of relaxation in the control. The residual relaxation after L-citrulline reversal was abolished by L-NNA and L-N-omega-nitro-L-Arg. At 1 mM, L-glutamate, tau-aminobutyric acid or NH4Cl did not block transmural nerve stimulation-induced relaxation, nor did Gln inhibit sodium nitroprusside-induced relaxation or neuronal NOS activity. These results provide pharmacological evidence that cerebral perivascular nerves can recycle L-citrulline to L-Arg for synthesizing nitric oxide to induce neurogenic vasodilation. Although the exact mechanism of action of Gln in inhibiting nitric oxidergic neurovascular transmission remains undetermined, Gln does not seem to act by releasing ammonium ions, inhibiting NOS or modifying the nitric oxide-cyclic GMP pathway. Cerebral metabolism of Gln may play an important role in regulating nitric oxidergic neurogenic vasodilation.
This article has been cited by other articles:
![]() |
Y. Hatanaka, N. Hobara, J. Honghua, S. Akiyama, H. Nawa, Y. Kobayashi, F. Takayama, Y. Gomita, and H. Kawasaki Neuronal Nitric-Oxide Synthase Inhibition Facilitates Adrenergic Neurotransmission in Rat Mesenteric Resistance Arteries J. Pharmacol. Exp. Ther., February 1, 2006; 316(2): 490 - 497. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kawaguchi, S. W. Brusilow, R. J. Traystman, and R. C. Koehler Glutamine-dependent inhibition of pial arteriolar dilation to acetylcholine with and without hyperammonemia in the rat Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2005; 288(6): R1612 - R1619. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Okada, Y. Watanabe, S. W. Brusilow, R. J. Traystman, and R. C. Koehler Interaction of glutamine and arginine on cerebrovascular reactivity to hypercapnia Am J Physiol Heart Circ Physiol, May 1, 2000; 278(5): H1577 - H1584. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ishine, J.-G. Yu, Y. Asada, and T. J.-F. Lee Nitric Oxide Is the Predominant Mediator for Neurogenic Vasodilation in Porcine Pial Veins J. Pharmacol. Exp. Ther., April 1, 1999; 289(1): 398 - 404. [Abstract] [Full Text] |
||||
![]() |
T. Hirata, T. Kawaguchi, S. W. Brusilow, R. J. Traystman, and R. C. Koehler Preserved hypocapnic pial arteriolar constriction during hyperammonemia by glutamine synthetase inhibition Am J Physiol Heart Circ Physiol, February 1, 1999; 276(2): H456 - H463. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Chakder and S. Rattan L-Arginine Deficiency Causes Suppression of Nonadrenergic Noncholinergic Nerve-Mediated Smooth Muscle Relaxation: Role of L-Citrulline Recycling J. Pharmacol. Exp. Ther., July 1, 1997; 282(1): 378 - 384. [Abstract] [Full Text] |
||||
![]() |
C. J. Meininger and G. Wu L-Glutamine Inhibits Nitric Oxide Synthesis in Bovine Venular Endothelial Cells J. Pharmacol. Exp. Ther., April 1, 1997; 281(1): 448 - 453. [Abstract] [Full Text] |
||||